Gyl Financial Synergies, LLC Eli Lilly & CO Transaction History

Gyl Financial Synergies, LLC

$1.31 Billion
Q3 2024

A detailed history of Gyl Financial Synergies, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gyl Financial Synergies, LLC holds 19,408 shares of LLY stock, worth $15.4 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

19,408

Previous 20,493 5.29%

Holding current value

$15.4 Million

Previous $18.6 Million 7.32%

% of portfolio

1.31%

Previous 1.45%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$772.14 - $960.02 $837,771 - $1.04 Million	-1,085 Reduced 5.29%	19,408 $17.2 Million
Q2 2024 Jul 23, 2024	BUY	$724.87 - $909.04 $22,470 - $28,180	31 Added 0.15%	20,493 $18.6 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $146,273 - $195,693	247 Added 1.22%	20,462 $15.9 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $1.37 Million - $1.62 Million	2,614 Added 14.85%	20,215 $11.8 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $13,910 - $19,177	32 Added 0.18%	17,601 $9.45 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $1.01 Million - $1.36 Million	2,892 Added 19.7%	17,569 $8.24 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $200,977 - $236,038	-647 Reduced 4.22%	14,677 $5.04 Million
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $87,140 - $101,535	271 Added 1.8%	15,324 $5.61 Million
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $63,743 - $72,642	215 Added 1.45%	15,053 $4.87 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $2.85 Million - $3.54 Million	12,674 Added 585.67%	14,838 $4.1 Million
Q3 2021 Nov 01, 2021	BUY	$221.6 - $272.71 $103,044 - $126,810	465 Added 27.37%	2,164 $500,000
Q1 2021 May 04, 2021	SELL	$164.32 - $212.72 $15,117 - $19,570	-92 Reduced 5.14%	1,699 $317,000
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $652 - $863	-5 Reduced 0.28%	1,791 $302,000
Q3 2020 Nov 06, 2020	BUY	$146.22 - $169.13 $1,023 - $1,183	7 Added 0.39%	1,796 $266,000
Q2 2020 Aug 04, 2020	BUY	$136.42 - $164.18 $1,773 - $2,134	13 Added 0.73%	1,789 $294,000
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $1,309 - $1,620	-11 Reduced 0.62%	1,776 $246,000
Q4 2019 Feb 06, 2020	SELL	$106.92 - $132.43 $46,189 - $57,209	-432 Reduced 19.47%	1,787 $235,000
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $28,940 - $31,479	271 Added 13.91%	2,219 $248,000
Q2 2019 Aug 09, 2019	BUY	$110.79 - $129.32 $110 - $129	1 Added 0.05%	1,948 $216,000
Q1 2019 May 21, 2019	SELL	$111.31 - $131.02 $188,113 - $221,423	-1,690 Reduced 46.47%	1,947 $253,000
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $188,336 - $221,685	1,692 Added 86.99%	3,637 $472,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $205,975 - $230,754	1,945 New	1,945 $225,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyl Financial Synergies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gyl Financial Synergies, LLC with notifications on news.

Account

Gyl Financial Synergies, LLC Eli Lilly & CO Transaction History